Policy and Design Considerations for Most-Favored-Nation Drug Pricing

This Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.

Authors

Olivier J. Wouters (ORCID: https://orcid.org/0000-0002-2514-476X)
Matthew Vogel

Institutions

Harvard University (US)
Brown University (US)

Publication Details

Journal: JAMA Internal Medicine
Published: 2026-09-28
DOI: https://doi.org/10.1001/jamainternmed.2026.4520
Primary Topic: Medication Adherence and Compliance
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

Policy and Design Considerations for Most-Favored-Nation Drug Pricing

Olivier J. Wouters, Matthew Vogel

Sep 28, 2026

JAMA Internal Medicine

Medication Adherence and Compliance

article

Policy and Design Considerations for Most-Favored-Nation Drug Pricing

Olivier J. Wouters, Matthew Vogel

September 28, 2026article en

Abstract

This Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.

JAMA Internal Medicine

Harvard University (US), Brown University (US)

Openalex Percentile: Top 9%

Medication Adherence and Compliance

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Policy and Design Considerations for Most-Favored-Nation Drug Pricing — Olivier J. Wouters, Matthew Vogel · JAMA Internal Medicine (2026) | TGRS Research Map | TGRS